Shashwat  Bhattacharyya

Shashwat Bhattacharyya

Profile ID RP-000-3120 Joined 2023-01-19 2 articles
3
Total Views
2
Total Publications
3
Publication Views

Articles(2)

Authors: Aditi Maitra, Shashwat Bhattacharyya, Kumaresh Chandra Sarkar, Shatavisha Mukherjee, Sambuddha Ghosh, Santanu Kumar Tripathi

DOI: 10.18231/j.pjms.2021.029  

Volume11

Issue1

Pages134-139

Abstract

Background: The paradox of open angle glaucoma therapy lies in the loss of reported efficacy of drugs when they are studied for real world effectiveness. Studies related to effectiveness and safety done in a longitudinal fashion in new cases of open angle glaucoma are scant. This study was undertaken to address the shortcomings in this regard. Materials and Methods: This was an open label, prospective, observational study. The patients were taken up for the study at their baseline visit and 3 subsequent follow up visits for next 6 months. The effectiveness was gauged on the basis of average IOP changes from baseline. Each patient was administered questionnaires for ocular surface disease and interviewed for possible adverse drug reactions at each follow up. Results: There were 68 participants who completed the study. All these patients reported at baseline and 3 subsequent follow ups. The mean baseline IOP was 27.20 (SD 6.29) mm of Hg and this reduced considerably to 16.97 mm of Hg (SD 3.18) which was a 37.61% reduction from the baseline (p

View Article

Authors: Smaranjit Biswas, Shashwat Bhattacharyya, Kanchan Kumar Mandal, Biswarup Ray

DOI: 10.18231/2395-1451.2018.0051  

Volume4

Issue2

Pages230-235

Abstract

Background: Rhinoconjunctivitis is a common health problem that plagues the lives of children and adolescents alike with a significant impairment of the quality of life. Purpose: Aim of this study was to investigate the effect of intranasal corticosteroid, fluticasone furoate, on the change of IOP in allergic rhinitis patients. Materials and Methods: This was a prospective observational study carried at the Ophthalmology outpatient department of a Government Medical College in West Bengal involving all consecutive patients attending ENT OPD for allergic rhinitis of age group 12 years and above and prescribed fluticasone furoate nasal spray. The IOP of patients were measured before and after start of steroid nasal spray and follow up was done at regular interval. One and half year and follow up was done on 1st, 2nd, 4th, 8th and 12th week respectively. Results: A total of 108 patients were selected for the study, out of which 100 remained till the end of all follow ups. The IOP for each eye was compared with baseline IOP values (RE: 16.02±2.29, LE: 16.04±2.20) and at the end of the study the P value for each follow up was calculated. The t test revealed that there was no significant change (increase/decrease) in IOP in any eye over the course of time. r values shows that there was a strong positive linear correlation of IOP between and within the eyes at different levels of assessment after the starting of the treatment. Even after age group adjustment, there was no statistical difference in IOP between the eyes among the various age groups. Conclusion: The study demonstrates no statistically significant increase in IOP after the administration of fluticasone furoate nasal spray. We believe, therefore, that fluticasone furoate administered for a short time for the treatment of nasal allergy, is safe in terms of its effect on IOP in the Indian population. Keywords: Allergic rhinoconjunctivitis, Fluticasone furoate, Intranasal steroids, Steroid induced glaucoma.

View Article

No matching articles

Try another word from the title, author or DOI.